{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:16:28Z","timestamp":1776377788918,"version":"3.51.2"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":196,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.14283\/jpad.2024.27","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T14:20:26Z","timestamp":1706106026000},"page":"310-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Estimates from Real-World Data"],"prefix":"10.1016","volume":"11","author":[{"given":"J.","family":"Chandler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Done","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urvi","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Georgieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gomez-Lievano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hilts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kirson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.14283\/jpad.2024.27_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/alz.12328","article-title":"2021 Alzheimer's disease facts and figures","volume":"17","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"9770","key":"10.14283\/jpad.2024.27_bib2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer's disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"10.14283\/jpad.2024.27_bib3","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-beta and tau in Alzheimer's disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat Neurosci"},{"issue":"16","key":"10.14283\/jpad.2024.27_bib4","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1212\/WNL.0b013e3182661f74","article-title":"Amyloid-beta assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study","volume":"79","author":"Doraiswamy","year":"2012","journal-title":"Neurology"},{"issue":"8 Suppl","key":"10.14283\/jpad.2024.27_bib5","first-page":"S177","article-title":"Economic burden of Alzheimer disease and managed care considerations","volume":"26","author":"Wong","year":"2020","journal-title":"Am J Manag Care"},{"key":"10.14283\/jpad.2024.27_bib6","author":"Centers for Disease Control and Prevention"},{"key":"10.14283\/jpad.2024.27_bib7","author":"Cavazzoni"},{"key":"10.14283\/jpad.2024.27_bib8","author":"Joszt"},{"issue":"1","key":"10.14283\/jpad.2024.27_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","article-title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Abeta protofibril antibody","volume":"13","author":"Swanson","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2024.27_bib10","author":"Rodriguez"},{"issue":"3","key":"10.14283\/jpad.2024.27_bib11","first-page":"37023","article-title":"Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer's Disease: A comprehensive review","volume":"10","author":"Haddad","year":"2022","journal-title":"Health Psychol Res"},{"issue":"1","key":"10.14283\/jpad.2024.27_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"18","key":"10.14283\/jpad.2024.27_bib13","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in Early Alzheimer's Disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.14283\/jpad.2024.27_bib14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZERALZ 2 Randomized Clinical Trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.14283\/jpad.2024.27_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12877-018-0748-9","article-title":"Potential cost savings to be made by slowing cognitive decline in mild Alzheimer's disease dementia using a model derived from the UK GERAS observational study","volume":"18","author":"Lenox-Smith","year":"2018","journal-title":"BMC Geriatr"},{"issue":"3","key":"10.14283\/jpad.2024.27_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3233\/JAD-160449","article-title":"What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study","volume":"57","author":"Reed","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.14283\/jpad.2024.27_bib17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3233\/JAD-220303","article-title":"Demonstration of Clinical Meaningfulness of the Integrated Alzheimer's Disease Rating Scale (iADRS): Association Between Change in iADRS Scores and Patient and Caregiver Health Outcomes","volume":"88","author":"Wessels","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2024.27_bib18","doi-asserted-by":"crossref","first-page":"e066611","DOI":"10.1002\/alz.066611","article-title":"Potential Savings in Caregiver Time and Societal Costs Associated with Slowing Disease Progression over 36 months in Patients with Early Alzheimer's Disease: Findings from GERASUS","volume":"18","author":"Chandler","year":"2022","journal-title":"Alzheimer's & Dementia"},{"key":"10.14283\/jpad.2024.27_bib19","author":"National Alzheimer's Coordinating Center"},{"issue":"4","key":"10.14283\/jpad.2024.27_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/WAD.0000000000000279","article-title":"Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set","volume":"32","author":"Besser","year":"2018","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.14283\/jpad.2024.27_bib21","author":"National Alzheimer's Coordinating Center"},{"issue":"3","key":"10.14283\/jpad.2024.27_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","article-title":"The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set","volume":"21","author":"Beekly","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"8","key":"10.14283\/jpad.2024.27_bib23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jnen\/nly049","article-title":"The Revised National Alzheimer's Coordinating Center's Neuropathology Form-Available Data and New Analyses","volume":"77","author":"Besser","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10.14283\/jpad.2024.27_bib24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s40120-021-00272-1","article-title":"Estimating Progression Rates Across the Spectrum of Alzheimer's Disease for Amyloid-Positive Individuals Using National Alzheimer's Coordinating Center Data","volume":"10","author":"Potashman","year":"2021","journal-title":"Neurol Ther"},{"issue":"3","key":"10.14283\/jpad.2024.27_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ana.410310303","article-title":"Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention","volume":"31","author":"Berg","year":"1992","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.14283\/jpad.2024.27_bib26","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jalz.2011.01.005","article-title":"Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials","volume":"7","author":"Coley","year":"2011","journal-title":"Alzheimer's & Dementia"},{"issue":"11","key":"10.14283\/jpad.2024.27_bib27","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): Current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"2","key":"10.14283\/jpad.2024.27_bib28","article-title":"Use of the Functional Activities Questionnaire in older adults with dementia","volume":"13","author":"Mayo AM","year":"2016","journal-title":"Hartford Inst Geriatr Nurs"},{"issue":"12","key":"10.14283\/jpad.2024.27_bib29","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.14283\/jpad.2024.27_bib31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2147\/NDT.S62323","article-title":"Disease progression model for Clinical Dementia Rating-Sum of Boxes in mild cognitive impairment and Alzheimer's subjects from the Alzheimer's Disease Neuroimaging Initiative","volume":"10","author":"Samtani","year":"2014","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"1 Supplement","key":"10.14283\/jpad.2024.27_bib32","first-page":"S39","article-title":"Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores","volume":"9","author":"Williams","year":"2013","journal-title":"Alzheimer's & Dementia"},{"issue":"4","key":"10.14283\/jpad.2024.27_bib33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/WAD.0b013e3181e2fc84","article-title":"Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease","volume":"24","author":"Teng","year":"2010","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"9","key":"10.14283\/jpad.2024.27_bib34","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s40520-018-1087-6","article-title":"Factors influencing attrition in 35 Alzheimer's Disease Centers across the USA: a longitudinal examination of the National Alzheimer's Coordinating Center's Uniform Data Set","volume":"31","author":"Burke","year":"2019","journal-title":"Aging Clin Exp Res"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T23:36:22Z","timestamp":1736465782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724000785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2274580724000785"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2024.27","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Estimates from Real-World Data","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2024.27","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}